Clinical trials
Diabetic Neuropathies trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 4 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Recruiting | 6 |
| Unknown status | 5 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Loma Linda University | 3 |
| Nevro Corp | 3 |
| Physicians Committee for Responsible Medicine | 2 |
| Southern California Institute for Research and Education | 2 |
| US Department of Veterans Affairs | 2 |
| Abbott Medical Devices | 1 |
| AdventHealth | 1 |
| Association of Extremity Nerve Surgeons | 1 |
| Axolotl Biologix | 1 |
| C5 Biomedical | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetic Neuropathies | 44 |
| Diabetes Mellitus | 16 |
| Diabetic Foot | 5 |
| Chronic Pain | 4 |
| Diabetes Complications | 4 |
| Diabetes Mellitus, Type 2 | 4 |
| Pain | 4 |
| Ulcer | 4 |
| Foot Diseases | 3 |
| Foot Ulcer | 3 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.